ライフサイエンスコーパス: after adjusting for

1 le-associated regions, which were negligible after adjusting for 11C-PiB.

2 Before and after adjusting for 14 resident characteristics, nursing

3 Mortality was higher among people with HIV after adjusting for age (adjusted hazard ratio [aHR] 1.4

4 tors for predicting reduced muscle endurance after adjusting for age (log10 GDF-15 [pg/mL] [B, -54.3

5 These correlations remained significant after adjusting for age (r = 0.41, P = 0.02; r = 0.47, P

6 related to physical functioning (p=5.9e-3), after adjusting for age and cell counts.

7 the effect of sex on FTP-signal for each ROI after adjusting for age and cohort.

8 CI, 1.58-2.90, P<0.0001), respectively, even after adjusting for age and comorbidity.

9 at diagnosis and less cognitive impairment, after adjusting for age and disease duration.

10 ericans showed the largest CDR and disc area after adjusting for age and gender (all P < 0.05).

11 After adjusting for age and iris color, qAF and RPE/BM c

12 After adjusting for age and left ventricular ejection fr

13 endently associated with the presence of HCC after adjusting for age and liver fibrosis stage, likely

14 uding global deficit score (P = 0.005), even after adjusting for age and nadir CD4 count.CONCLUSIONHI

15 ey injury (odds ratio, 2.7; 95% CI, 1.4-4.9) after adjusting for age and National Institutes of Healt

16 unts in the home had more severe MG dropout, after adjusting for age and other confounders.

17 After adjusting for age and sex, each unit increase in L

18 After adjusting for age and sex, very low BMD remained a

19 es throughout recovery versus those without, after adjusting for age and sex.

20 patients with IBD compared to those with NIC after adjusting for age and sex.

21 isk of COVID-19 death than those without HIV after adjusting for age and sex: hazard ratio (HR) 2.90

22 h lung transplantation as a censoring event, after adjusting for age at diagnosis and sex (Stanford H

23 After adjusting for age at diagnosis, age at questionnai

24 After adjusting for age, AD POAG patients had different

25 The results were similar after adjusting for age, body height, and scanning radiu

26 ndently associated with increased mortality, after adjusting for age, clinical and echocardiographic

27 After adjusting for age, comorbidities, and hospital eff

28 p=0.011).The difference remained significant after adjusting for age, current sexual relationship, an

29 After adjusting for age, disc area, and other confounder

30 After adjusting for age, gender, Acute Physiology and Ch

31 After adjusting for age, gender, and baseline RV/LV rati

32 After adjusting for age, gender, and cardiovascular risk

33 After adjusting for age, gender, and comorbidities, chem

34 between IMD-W and other serogroups remained after adjusting for age, gender, and comorbidities.

35 After adjusting for age, gender, baseline BCVA and AMD s

36 After adjusting for age, gender, ethnicity, intraocular

37 After adjusting for age, gender, ethnicity, MAP, IOP, bo

38 mmHg (95% CI, 0.75-0.79 mmHg), respectively, after adjusting for age, gender, glaucoma, age-related m

39 After adjusting for age, gender, Pediatric Risk of Morta

40 rred 43% increased odds of in-hospital death after adjusting for age, gender, race, body mass index,

41 n multivariate logistic regression analysis, after adjusting for age, gender, transplant indication,

42 After adjusting for age, geography, and subspecialty, wo

43 that mean body temperature in men and women, after adjusting for age, height, weight and, in some mod

44 ercourse (adjusted odds ratio 3.90, p<0.001) after adjusting for age, HIV status, and condom use.

45 rcourse (adjusted odds ratio 3.90; P < .001) after adjusting for age, human immunodeficiency virus st

46 After adjusting for age, iris color, and gender, the cor

47 After adjusting for age, race, and gender, the OR compar

48 ences did not reach statistical significance after adjusting for age, race, HIV risk group, and cohor

49 After adjusting for age, sex and alcohol use, white and

50 regions of interest tau uptake from tau-PET) after adjusting for age, sex and hypertension.

51 After adjusting for age, sex and race, odds ratio of inf

52 ion (relative risk, 0.96; 95% CI, 0.77-1.19) after adjusting for age, sex, and comorbidities.

53 mortality was not statistically significant after adjusting for age, sex, and multisystem organ dysf

54 After adjusting for age, sex, and race, annual all-cause

55 for mean airway pressure; 95% CI, 1.10-1.74) after adjusting for age, sex, baseline Acute Physiology

56 s 34%; P = .01); this relationship persisted after adjusting for age, sex, BMIZ, elevated BP, and hyp

57 After adjusting for age, sex, body mass index (BMI), and

58 These associations remained significant after adjusting for age, sex, body mass index, type 2 di

59 he hazard ratio was 2.48 (95% CI, 1.29-4.78) after adjusting for age, sex, cardiovascular risk factor

60 -year incidence of respiratory exacerbations after adjusting for age, sex, current smoking, body mass

61 nd increased central macular ChT (P < .001), after adjusting for age, sex, ethnicity, and ocular meas

62 This association remained after adjusting for age, sex, height, smoking status, us

63 After adjusting for age, sex, listing status, and inotro

64 d with prior HTN (OR 1.31, 95% CI 1.29-1.33) after adjusting for age, sex, monthly income, geographic

65 After adjusting for age, sex, nutritional status, and pa

66 e impairment (aOR = 3.45, 95% CI: 2.20-5.41) after adjusting for age, sex, race, and income.

67 lized (log10 VL = 3.3 versus 4.0; P = 0.018) after adjusting for age, sex, race, body mass index, and

68 n GDF-15 and the primary end point persisted after adjusting for age, sex, race, body mass index, est

69 t result for SARS-CoV-2 in African Americans after adjusting for age, sex, race, smoking history, and

70 After adjusting for age, sex, type of atrial fibrillatio

71 ntly associated with colon polyp types, even after adjusting for age, smoking, and body mass index or

72 fidence interval 1.01-7.40, p-value = 0.047)-after adjusting for age, time period (before or after 20

73 After adjusting for age, waist-to-hip ratio (WHR), glyca

74 vel on unilateral or bilateral VI were > 10% after adjusting for age.

75 In comparison, after adjusting for alcohol consumption, smoking retaine

76 oking to be a risk factor for many CVDs even after adjusting for alcohol.

77 These observations were consistent after adjusting for all covariates.

78 Furthermore, after adjusting for all variables showing the associatio

79 6) reported usually drinking with meals and, after adjusting for amount consumed, cirrhosis incidence

80 After adjusting for baseline and time-varying confounder

81 congestion strongly predicted outcomes even after adjusting for baseline congestion (P<0.001).

82 After adjusting for baseline differences, readmission ra

83 pared with 35%; 95% CI: 33%, 37%, P = 0.047) after adjusting for baseline measurements.

84 After adjusting for baseline outcome and study location,

85 ween study arms in terms of placenta malaria after adjusting for birth season, parity, and IPTp-SP do

86 e premeditation and perseverance, before and after adjusting for BMI.

87 ing future diabetes among middle-aged adults after adjusting for body mass index (BMI).

88 ently associated with mortality at 3 months, after adjusting for brain herniation, admission Glasgow

89 After adjusting for brand and flavor, the mean glucan co

90 .14 mm(2), P=0.004) and remained significant after adjusting for cardiovascular risk factors and psor

91 nder women compared with cisgender men, even after adjusting for cardiovascular risk factors.

92 (HR: 1.11; 95% CI: 1.03 to 1.20; p = 0.006) after adjusting for cardiovascular risk factors.

93 ofessor 13.0% vs 37.2%) were not significant after adjusting for career duration (P = .083, .459, and

94 e was observed when assessed with burst area after adjusting for carotid beta-stiffness (-116.1 +/- 1

95 .006) in OpTrust scores (overall range 2-8), after adjusting for case difficulty, faculty experience,

96 not to be utilized for transplantation even after adjusting for changes in donor characteristics.

97 After adjusting for changes in inflation, population siz

98 After adjusting for classical risk factors, the hazard r

99 significantly associated with mortality also after adjusting for clinical and biochemical covariates

100 s significantly associated with elevated ECV after adjusting for clinical and imaging covariates: bet

101 vival in HPSCC compared with LSCC before and after adjusting for clinical parameters.

102 After adjusting for clinical risk factors, a higher GRS

103 apping and was associated with AF recurrence after adjusting for clinical risk factors, including bod

104 5)), but the association was not significant after adjusting for clinical risk factors.

105 After adjusting for clinical severity and location, type

106 p (P = 0.001), with a HR of 2.23 (1.37-3.65) after adjusting for clinical variables.

107 After adjusting for clinicopathologic and treatment char

108 After adjusting for clustering, the risk of treatment fa

109 After adjusting for confounders and child height, we obs

110 Among former smokers, after adjusting for confounders, each additional year si

111 After adjusting for confounders, each unit decrease in p

112 iated with reductions in health expenditures after adjusting for confounders, especially in inpatient

113 After adjusting for confounders, HIV remained significan

114 ve VTE chemoprophylaxis was broadly applied, after adjusting for confounders, no reduction in VTE was

115 After adjusting for confounders, overlapping surgery was

116 After adjusting for confounders, participants with glauc

117 After adjusting for confounders, plasma levels of elasti

118 After adjusting for confounders, senile sclerotic discs

119 After adjusting for confounders, the adjusted HRs for IO

120 nfidence interval [CI] 0.59, 0.73; P < .001) after adjusting for confounders.

121 ber layer (cpRNFL) thickness in the 2 groups after adjusting for confounders.

122 to evaluate diagnostic accuracy among groups after adjusting for confounders.

123 laucoma, this relationship actually reversed after adjusting for confounders.

124 After adjusting for confounding factors, increased maxim

125 After adjusting for confounding factors, the frequency o

126 In males, after adjusting for confounding factors, the highest SUA

127 rcRNA levels and HCM remained unchanged even after adjusting for confounding factors.

128 patients treated with daptomycin monotherapy after adjusting for confounding variables using inverse

129 iation in Black children slightly attenuated after adjusting for cord plasma creatinine (P = 0.05).

130 ce interval, 0.79-0.94 per mmHg CH increase) after adjusting for covariables.

131 After adjusting for covariates, each 10-count increase i

132 After adjusting for covariates, each 5-mug/dL higher chi

133 After adjusting for covariates, high plasma folate and h

134 After adjusting for covariates, individual n-3 eicosapen

135 After adjusting for covariates, only advanced hepatic fi

136 This remained true after adjusting for covariates.

137 rd ratio, 3.31 [95% CI, 1.93-5.67]; P<0.001) after adjusting for covariates.

138 rogeneity in the risks of incidents remained after adjusting for covariates.

139 (LDL)-cholesterol, and remained significant after adjusting for current FM.

140 being transgender and myocardial infarction after adjusting for CVD risk factors including age, diab

141 After adjusting for demographic and clinical factors, th

142 ntation (KT) compared with Whites (WH), even after adjusting for demographic and medical factors.

143 tios (O/Es) were calculated for each measure after adjusting for demographic characteristics and dise

144 10-unit increment: 0.87 (95% CI: 0.81, 0.93) after adjusting for demographic, lifestyle, and other di

145 us on the risk of incident amputation events after adjusting for demographics and cardiovascular risk

146 tion and stroke) risk and overall mortality, after adjusting for demographics and CVD risk factors.

147 d seven ethnic group-specific bacterial taxa after adjusting for dental plaque index, decayed missing

148 After adjusting for depression symptoms, the PTSD findin

149 dren were more likely to have high MLVI even after adjusting for deprivation (adjusted odds ratio 4.0

150 After adjusting for diabetes and measured BP, chi-square

151 -0.85% to 2.28%]) were no longer significant after adjusting for dietary cholesterol consumption.

152 After adjusting for differences between groups, receipt

153 DL-C levels with the risk of CHD became null after adjusting for differences in ApoB (triglycerides:

154 Moreover, after adjusting for differences in brain volumes determi

155 After adjusting for disease severity and relevant clinic

156 After adjusting for disease severity, DMMB-GAG was signi

157 After adjusting for disease severity, patients with anti

158 was associated with increased risk of death after adjusting for disease stage [PAM negative, HR = 13

159 After adjusting for donor characteristics, increased len

160 y with donor injury biomarker concentrations after adjusting for donor, transplant, and recipient cha

161 {\beta }}_{{\rm{Adj}}}^{{\rm{STD}}}$= -0.12] after adjusting for elapsed time since surgery and type

162 th patients with cytoplasmic positive tumors after adjusting for ER, PR, and HER2 status.

163 ation cohort, and 3.04 (2.07-4.47; p<0.0001) after adjusting for established prognostic markers signi

164 ssociations between allergic diseases and HL after adjusting for established risk factors.

165 After adjusting for familial atopic disease, maternal do

166 After adjusting for family ascertainment, breast cancer

167 adults who did not take vitamin E (controls) after adjusting for fibrosis severity, age, gender, body

168 uL or greater were associated with mortality after adjusting for forced vital capacity (HR 2.47, 95%

169 After adjusting for gains in fat-free mass and fat mass,

170 d at 3 y, remained independently significant after adjusting for gender and age at diagnosis, two oth

171 age acceleration in AUD compared to controls after adjusting for gender and blood cell composition (p

172 ide (adjusted OR 1.76 [1.32-2.34], p<0.0001) after adjusting for gender, age, previous self-harm, and

173 These WHR associations persisted after adjusting for genetic determinants of BMI.

174 nostic in females and low valve area but not after adjusting for gradients.

175 = .04); however, no association was observed after adjusting for HAI titers.

176 =0.04), however, no association was observed after adjusting for HAI titers.

177 4.2 [95% CI, 2.2-7.5]) predicted moderate DR after adjusting for HbA1C and blood pressure.

178 age 85; these relationships were maintained after adjusting for health behaviors.

179 nt is most strongly related to inflammation, after adjusting for health behaviours, body mass index a

180 revalence and the highest associated IE risk after adjusting for IE risk factors.

181 After adjusting for illness severity and institution, pa

182 index (beta=0.14, p=0.068), which diminished after adjusting for imaging markers for SVD.

183 After adjusting for imbalances in baseline and implement

184 io, 0.10 [95% confidence interval, .06-.17]) after adjusting for infection with enterococci, Charlson

185 After adjusting for inflation, Medicare reimbursement ra

186 After adjusting for IPI, patients with concurrent DLBCL

187 did not influence the rate of change in DVA after adjusting for key covariates.

188 d CA-SABSI remained significantly associated after adjusting for known risk factors (OR 5, 3.3 to 7.5

189 Regression analysis after adjusting for likely confounders showed that B12 w

190 After adjusting for LOS, neither CIT nor DGF were indepe

191 tly associated with an increased risk of NCI after adjusting for major confounders.

192 After adjusting for major risk factors, we found that me

193 aternal diet and change in postpartum weight after adjusting for maternal age, height, and energy int

194 erence in Black patients was not significant after adjusting for mediating factors.

195 After adjusting for medical complexity, the mean MIPS sc

196 idney transplant wait-listing persisted even after adjusting for medical factors and social determina

197 l, 0.60-0.96) to be wait-listed than WH even after adjusting for medical factors and social determina

198 kidney transplant waitlisting persisted even after adjusting for medical factors and social determina

199 al, 0.60-0.96) to be waitlisted than WH even after adjusting for medical factors and social determina

200 atio, 0.95; 95% CI, 0.93-0.98; p = 0.001) or after adjusting for Model for End-stage Liver Disease or

201 lity for each threshold remained significant after adjusting for model for end-stage liver disease-so

202 MSE scale 5 remained significant predictors after adjusting for multiple clinical variables.

203 hough no significant interactions were found after adjusting for multiple comparisons.

204 ases with worsening eGFR at waitlisting even after adjusting for multiple confounders.

205 the increased risk persisted in females even after adjusting for multiple conventional risk factors a

206 12 were associated with worse VA at month 12 after adjusting for multiple factors, whereas PCV subtyp

207 er than those who passed their first attempt after adjusting for multiple surgeon characteristics (ad

208 th levels of antimony, arsenic, and mercury, after adjusting for multiple testing.

209 is independently associated with CAD events after adjusting for multiple traditional and HIV-related

210 After adjusting for multiple variables, there was no dif

211 e associations were substantially attenuated after adjusting for non-genetic mortality risk factors m

212 After adjusting for non-specific binding to PEG-coated b

213 t this association was no longer significant after adjusting for obesity, a risk factor for both cond

214 After adjusting for observational bias, the proposed mod

215 ts on offspring cardiometabolic risk factors after adjusting for offspring GRS.

216 ed with an increased risk of type 1 diabetes after adjusting for other antiasthmatic drugs, asthma, s

217 After adjusting for other confounders, CFU and age remai

218 associated with cardiovascular disease even after adjusting for other inflammatory markers.

219 e study cohorts, and these effects persisted after adjusting for other previously established risk fa

220 ith risk of distal colon and rectal cancers, after adjusting for other risk factors (multivariable re

221 These associations were attenuated after adjusting for other shared risk factors, with a si

222 er education (OR = 3.94; 95%CI: 2.74, 5.67), after adjusting for other TB risk factors (age, sex, BCG

223 ue of patients' characteristics for survival after adjusting for other variates.

224 Similar results were obtained after adjusting for participating sites, age, preexistin

225 After adjusting for patient and center characteristics,

226 Cox proportional hazards analysis, after adjusting for patient and hospital characteristics

227 outcomes between antibiotic treatment groups after adjusting for patient characteristics, surrogate m

228 After adjusting for patient demographics, year of consul

229 1-3, respectively, compared with quintile 5] after adjusting for patient factors, hospital type, and

230 After adjusting for peripheral hearing function and perf

231 Even after adjusting for physiologic differences, YLPHIV appe

232 tions were found for all interventions, even after adjusting for population characteristics, indicati

233 ssociated with the primary end point but not after adjusting for positive exercise tolerance testing.

234 m paraoxonase were associated with mortality after adjusting for possible confounders.

235 primary outcome did not substantially change after adjusting for possible effect moderators or in sen

236 significant predictor of facial recognition after adjusting for potential confounders including glau

237 After adjusting for potential confounders, a positive as

238 ociations remained statistically significant after adjusting for potential confounders, including cal

239 After adjusting for potential confounders, the RRs (95%

240 te rejection and disease recurrence remained after adjusting for potential confounders.

241 These associations remained significant after adjusting for potential confounders.

242 risk factor for mortality or HCC recurrence after adjusting for potential confounders.

243 After adjusting for potential covariates, the pooled HR

244 postchemotherapy participants than controls after adjusting for previous vaccine doses (P < .001).

245 ols with minimal overlap, and this persisted after adjusting for primary comorbidities: body mass ind

246 After adjusting for prior surveillance, the risk of adva

247 hazard ratios for adverse clinical outcomes, after adjusting for procedure type, treatment indication

248 After adjusting for PRSs, parental history still strongl

249 k 4, and this reduction remained significant after adjusting for QIDS-C change (adjusted effect size=

250 This association remained significant after adjusting for race, body mass index, and smoking s

251 dicaid group were significantly more likely (after adjusting for race/ethnicity) to 1) go to sleep wh

252 more likely to be prescribed antidepressants after adjusting for region.

253 After adjusting for relevant confounders, concurrent ant

254 -2 (Dallas Heart Study phase 2) participants after adjusting for relevant variables.

255 ficantly associated with rotavirus infection after adjusting for seasonality and between-site variati

256 This effect remained unchanged after adjusting for self-reported adherence.

257 However, after adjusting for sepsis-specific patient characterist

258 After adjusting for several potential confounders, inclu

259 or 1-AU increase of sAF [95% CI 1.46-11.71]) after adjusting for several potential confounders.

260 ant increase in CSF C4 levels between groups after adjusting for sex and age.

261 between the East Village and control groups, after adjusting for sex, age group, ethnicity, housing t

262 After adjusting for sex, ethnicity, hypertension, CD4 ce

263 .003 unadjusted), which remained significant after adjusting for sex, New York Heart Association func

264 risk of nonrelapse mortality (NRM; P = .001) after adjusting for significant clinical and genetic var

265 racial disparity in KT waitlisting persists after adjusting for social determinants of health (eg, c

266 After adjusting for sociodemographic and other factors,

267 After adjusting for sociodemographic factors, patients w

268 After adjusting for sociodemographic/medical history, BM

269 mental health advantage over whites widened after adjusting for socioeconomic factors.

270 ex and -load diets were partially attenuated after adjusting for soluble fiber intake.

271 After adjusting for steroid use or donor type, this comp

272 18; 95% CI, 3.04-12.57), with minimal change after adjusting for steroids.

273 icantly associated with SARS-CoV-2 infection after adjusting for strict social distancing and demogra

274 After adjusting for surgical wait time, the odds ratio d

275 After adjusting for temporal trends, seven-day lagged an

276 After adjusting for testing frequency, the increase in i

277 After adjusting for the acute-phase response, serum ferr

278 10(-3); hazard ratio: 1.74:95%CI: 1.16-2.59) after adjusting for the baseline confounders.

279 C allele of CFH rs1329428 (P = 3.0 x 10(-3)) after adjusting for the baseline confounders.

280 ependently associated with delirium severity after adjusting for the change in inflammation (DeltaR2

281 After adjusting for the correlation within inpatient uni

282 sity was associated with poor IHCA outcomes, after adjusting for the effects of BMI.

283 odds ratio [OR] 0.82 [95% CI 0.71-0.94]) and after adjusting for the increased disease severity of pa

284 se-treated patients increased annually, even after adjusting for the number of spokes in the network

285 After adjusting for the number of visits and patients, s

286 2.14; p=0.05), and the association persisted after adjusting for the other variables (aHR 1.69; 95% C

287 f graft failure with each structural feature after adjusting for the predictive clinical characterist

288 These findings persisted after adjusting for the presence of late gadolinium enha

289 After adjusting for time on LVAD, for every 1 cm(2)/m(2)

290 After adjusting for time to FU, increasing N1 and P1 IT

291 ajor adverse kidney events (p = 0.046), even after adjusting for timing of continuous renal replaceme

292 ciation between step intensity and mortality after adjusting for total steps per day.

293 After adjusting for traditional risk factors, the AIP wa

294 After adjusting for traditional risk factors, we identif

295 After adjusting for transfusion type and baseline FACT-B

296 ive factors were determined, unadjusted, and after adjusting for variables including age, initial bod

297 compared to control patients both before and after adjusting for various baseline factors [adjusted s

298 0.95; P-trend = 0.0002); this was attenuated after adjusting for weight change since age 18 y (MVHRQ5

299 ffect of metabolic surgery was still present after adjusting for weight loss amounts, suggesting that

300 sociated with CSCC recurrence and metastasis after adjusting for well-established CSCC risk factors.